Human genome analysis project to identify risk factors of HBV reactivation following rituximab plus steroids containing chemotherapy (C-SHOT1402)
Not Applicable
- Conditions
- Malignant lymphoma
- Registration Number
- JPRN-UMIN000016177
- Lead Sponsor
- The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine/Department of Human Genetics, Graduate School of Medicine, University of Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1)younger than 19 years old 2)not ability for enough judgement even if 20 years old or older 3) not consciousness even if 20 years old or older 4) careful consideration for the notice of illness is necessary 5) Other conditions considered inappropriate by a physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Host risk factors for HBV reactivation
- Secondary Outcome Measures
Name Time Method